Published in Infect Immun on January 01, 2002
Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev (2003) 4.14
Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS Pathog (2010) 2.06
GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism. Genome Biol (2007) 1.99
Role of narK2X and narGHJI in hypoxic upregulation of nitrate reduction by Mycobacterium tuberculosis. J Bacteriol (2003) 1.58
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses. Immunol Rev (2015) 1.45
Uptake of carbon monoxide and hydrogen at environmentally relevant concentrations by mycobacteria. Appl Environ Microbiol (2003) 1.34
Compiling a molecular inventory for Mycobacterium bovis BCG at two growth rates: evidence for growth rate-mediated regulation of ribosome biosynthesis and lipid metabolism. J Bacteriol (2005) 1.28
Identification of Pseudomonas aeruginosa genes involved in virulence and anaerobic growth. Infect Immun (2006) 1.27
Polymorphic nucleotide within the promoter of nitrate reductase (NarGHJI) is specific for Mycobacterium tuberculosis. J Clin Microbiol (2003) 1.27
Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration. J Bacteriol (2008) 1.26
Nitrate sensing and metabolism modulate motility, biofilm formation, and virulence in Pseudomonas aeruginosa. Infect Immun (2007) 1.24
Ribonucleotide reduction in Mycobacterium tuberculosis: function and expression of genes encoding class Ib and class II ribonucleotide reductases. Infect Immun (2003) 1.23
Role of FNR and FNR-regulated, sugar fermentation genes in Neisseria meningitidis infection. Mol Microbiol (2006) 1.17
Enzymes involved in anaerobic respiration appear to play a role in Actinobacillus pleuropneumoniae virulence. Infect Immun (2005) 1.16
Identification of dimethyl sulfoxide reductase in Actinobacillus pleuropneumoniae and its role in infection. Infect Immun (2003) 1.14
Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism. Infect Immun (2003) 1.14
Evolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker? Tuberc Res Treat (2015) 1.08
Latent tuberculosis infection: myths, models, and molecular mechanisms. Microbiol Mol Biol Rev (2014) 1.06
A promoter mutation causes differential nitrate reductase activity of Mycobacterium tuberculosis and Mycobacterium bovis. J Bacteriol (2004) 1.03
Mycobacterium bovis BCG vaccine strains lack narK2 and narX induction and exhibit altered phenotypes during dormancy. Infect Immun (2008) 1.03
Functional analysis of molybdopterin biosynthesis in mycobacteria identifies a fused molybdopterin synthase in Mycobacterium tuberculosis. J Bacteriol (2010) 1.02
Genome-wide discovery of small RNAs in Mycobacterium tuberculosis. PLoS One (2012) 1.00
The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria. Infect Immun (2013) 0.98
Modulation of gene expression in Actinobacillus pleuropneumoniae exposed to bronchoalveolar fluid. PLoS One (2009) 0.92
Improvement in mycobacterial yield and reduced time to detection in pediatric samples by use of a nutrient broth growth supplement. J Clin Microbiol (2009) 0.92
Mutation and virulence assessment of chromosomal genes of Rhodococcus equi 103. Can J Vet Res (2007) 0.84
Mutational analysis of the respiratory nitrate transporter NarK2 of Mycobacterium tuberculosis. PLoS One (2012) 0.83
Differential producibility analysis (DPA) of transcriptomic data with metabolic networks: deconstructing the metabolic response of M. tuberculosis. PLoS Comput Biol (2011) 0.82
Mycobacterial MazG safeguards genetic stability via housecleaning of 5-OH-dCTP. PLoS Pathog (2013) 0.79
Experimental selection of long-term intracellular mycobacteria. Cell Microbiol (2014) 0.79
Transcription of genes involved in sulfolipid and polyacyltrehalose biosynthesis of Mycobacterium tuberculosis in experimental latent tuberculosis infection. PLoS One (2013) 0.77
bis-Molybdopterin guanine dinucleotide is required for persistence of Mycobacterium tuberculosis in guinea pigs. Infect Immun (2014) 0.77
Mechanistic Investigation of cPMP Synthase in Molybdenum Cofactor Biosynthesis Using an Uncleavable Substrate Analogue. Biochemistry (2015) 0.76
POTION: an end-to-end pipeline for positive Darwinian selection detection in genome-scale data through phylogenetic comparison of protein-coding genes. BMC Genomics (2015) 0.76
A Novel, Molybdenum-Containing Methionine Sulfoxide Reductase Supports Survival of Haemophilus influenzae in an In vivo Model of Infection. Front Microbiol (2016) 0.75
Rapid testing for nitrate reductase activity of Mycobacterium tuberculosis grown in an automated culture system. Eur J Clin Microbiol Infect Dis (2003) 0.75
Comparison of gene expression profiles between pansensitive and multidrug-resistant strains of Mycobacterium tuberculosis. Curr Microbiol (2013) 0.75
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62
New use of BCG for recombinant vaccines. Nature (1991) 14.40
Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature (2000) 11.48
A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med (1996) 7.66
Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med (1996) 5.36
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science (1998) 4.58
Mammalian nitric oxide synthases. Biochim Biophys Acta (1999) 3.55
Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun (1991) 3.54
Disseminated bacille Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis (1997) 3.34
Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol (2000) 3.14
Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat Med (2000) 2.97
Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature (1991) 2.83
A study of nitrate reduction by mycobacteria. The use of the nitrate reduction test in the identification of mycobacteria. Acta Tuberc Scand Suppl (1960) 2.33
Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest (1998) 2.30
Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice. Mol Microbiol (2000) 2.18
Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study. Pediatrics (1996) 2.14
The anaerobic life of Bacillus subtilis: cloning of the genes encoding the respiratory nitrate reductase system. FEMS Microbiol Lett (1995) 2.14
Immunological conditions of children with BCG disseminated infection. Lancet (1995) 2.05
Nitric oxide and mitochondrial respiration. Biochim Biophys Acta (1999) 2.02
Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis. Tuber Lung Dis (1998) 1.99
Nitric oxide produced during murine listeriosis is protective. Infect Immun (1994) 1.93
Nitrate reductase of Escherichia coli: completion of the nucleotide sequence of the nar operon and reassessment of the role of the alpha and beta subunits in iron binding and electron transfer. Mol Gen Genet (1989) 1.90
Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63. Proc Natl Acad Sci U S A (1993) 1.76
Nitric oxide metabolism and breakdown. Biochim Biophys Acta (1999) 1.74
Studies on the nitrate reductase activity of mycobacteria in the presence of fatty acids and related compounds. Am Rev Respir Dis (1970) 1.71
Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature (1994) 1.69
Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol (1997) 1.47
Human immunodeficiency virus infection and routine childhood immunisation. Lancet (1987) 1.42
Dissimilatory nitrate reductases in bacteria. Biochim Biophys Acta (1999) 1.39
Up-regulation of narX, encoding a putative 'fused nitrate reductase' in anaerobic dormant Mycobacterium bovis BCG. FEMS Microbiol Lett (1999) 1.30
Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals. Proc Natl Acad Sci U S A (1995) 1.17
Analysis of the dormancy-inducible narK2 promoter in Mycobacterium bovis BCG. FEMS Microbiol Lett (2000) 1.09
Purification of the dissimilative nitrate reductase of Pseudomonas fluorescens and the cloning and sequencing of its corresponding genes. Biochim Biophys Acta (1997) 1.04
On the occurrence of epitheloid cell granulomas in the organs of BCG-vaccinated human beings. Acta Pathol Microbiol Scand Suppl (1956) 1.04
The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDS. AIDS (1993) 0.95
Disseminated tuberculoid lesions in infants following BCG vaccination. Can Med Assoc J (1982) 0.84
Disseminated infection with Bacillus Calmette-Guerin in a child with advanced HIV disease. Scand J Infect Dis (1997) 0.80
Rapid-cycle PCR and fluorimetry for detection of mycobacteria. J Clin Microbiol (2002) 2.02
Candida kefyr as an emerging pathogen causing nosocomial bloodstream infections in neutropenic leukemia patients. Clin Infect Dis (2005) 1.83
The roles of the nitrate reductase NarGHJI, the nitrite reductase NirBD and the response regulator GlnR in nitrate assimilation of Mycobacterium tuberculosis. Microbiology (2009) 1.35
Polymorphic nucleotide within the promoter of nitrate reductase (NarGHJI) is specific for Mycobacterium tuberculosis. J Clin Microbiol (2003) 1.27
Benign cystic mesothelioma of the liver. Am J Surg Pathol (2002) 1.11
Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005-2011. BMC Infect Dis (2013) 1.10
Role of the transcriptional regulator RamB (Rv0465c) in the control of the glyoxylate cycle in Mycobacterium tuberculosis. J Bacteriol (2009) 1.10
A promoter mutation causes differential nitrate reductase activity of Mycobacterium tuberculosis and Mycobacterium bovis. J Bacteriol (2004) 1.03
Thiol peroxidase protects Salmonella enterica from hydrogen peroxide stress in vitro and facilitates intracellular growth. J Bacteriol (2010) 1.03
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo. J Hepatol (2011) 0.98
The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria. Infect Immun (2013) 0.98
Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation. Am J Gastroenterol (2006) 0.97
Intrathyroidal thymic tissue surrounding an intrathyroidal parathyroid gland, the cause of a solitary thyroid nodule in a 6-year-old boy. Thyroid (2008) 0.95
IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet. Gastroenterology (2006) 0.92
Instruction of haematopoietic lineage choices, evolution of transcriptional landscapes and cancer stem cell hierarchies derived from an AML1-ETO mouse model. EMBO Mol Med (2013) 0.92
Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys (2011) 0.91
Donor and host B cell-derived IL-10 contributes to suppression of graft-versus-host disease. Eur J Immunol (2014) 0.91
Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens. J Clin Microbiol (2013) 0.90
Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease. Br J Haematol (2006) 0.89
Methionine sulfoxide reductases are essential for virulence of Salmonella typhimurium. PLoS One (2011) 0.89
Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI. J Magn Reson Imaging (2012) 0.88
Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe. J Infect (2005) 0.87
Successful treatment of adult multisystemic Langerhans cell histiocytosis with psoralen-UV-A, prednisolone, mercaptopurine, and vinblastine. Arch Dermatol (2008) 0.86
Metabolic adaptation of Mycobacterium avium subsp. paratuberculosis to the gut environment. Microbiology (2012) 0.86
STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2. Cancer Res (2012) 0.85
Epulis granulomatosa as an oral manifestation of Klippel-Trénaunay syndrome. J Oral Pathol Med (2006) 0.84
Rectal Cancer: MR imaging of the mesorectal fascia and effect of chemoradiation on assessment of tumor involvement. J Magn Reson Imaging (2012) 0.81
Anaerobic arginine metabolism of Mycobacterium tuberculosis is mediated by arginine deiminase (arcA), but is not essential for chronic persistence in an aerogenic mouse model of infection. Int J Med Microbiol (2007) 0.79
[Post-mortal detection of clostridia--putrefaction or infection?]. Arch Kriminol (2010) 0.78
Analysis of expression and regulatory functions of the ribosome-binding protein TypA in Mycobacterium tuberculosis under stress conditions. Arch Microbiol (2010) 0.78
Early surfactant guided by lamellar body counts on gastric aspirate in very preterm infants. Neonatology (2013) 0.77
Biotin sulfoxide reductase contributes to oxidative stress tolerance and virulence in Salmonella enterica serovar Typhimurium. Microbiology (2013) 0.77
In vitro and in vivo characterization of a Mycobacterium tuberculosis mutant deficient in glycosyltransferase Rv1500. Int J Med Microbiol (2008) 0.77
Mechanisms of cyclic nucleotide phosphodiesterases in modulating T cell responses in murine graft-versus-host disease. PLoS One (2013) 0.77
[Postnatal sepsis due to group A Streptococcus in a mother and her newborn]. Arch Kriminol (2009) 0.75
Liver resection for concomitant colorectal liver metastases and intrahepatic cholangiocarcinoma: a rare combination. Int J Colorectal Dis (2009) 0.75
Multidrug resistant tuberculosis in a 6 year old child. Paediatr Respir Rev (2007) 0.75
Ultrasound presentation of abdominal tuberculosis in a German tertiary care center. Scand J Gastroenterol (2013) 0.75
Synthetic lipopeptide MALP-2 inhibits intracellular growth of Mycobacterium bovis BCG in alveolar macrophages-preliminary data. Inflammation (2009) 0.75